Prescribing patterns of non-steroidal anti-inflammatory drugs in chronic kidney disease patients in the South African private sector
- 435 Downloads
Background Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used pharmaceutical agents worldwide. NSAIDs are considered nephrotoxic and should therefore be used with caution or be avoided completely in high risk patients, such as chronic kidney disease (CKD) patients. Objective This study aimed to investigate the prescribing of NSAIDs in CKD patients in order to generate awareness and improve the outcome of these patients. Setting The study was conducted using medicine claims data in the private health sector of South Africa. Method A descriptive, quantitative study was performed, using retrospective data obtained from a Pharmaceutical Benefit Management company. Data from 1 January 2009 to 31 December 2013 were analysed. The study population consisted of all patients with an ICD-10 code for a CKD (N18), in association with a paid claim for an NSAID. Main outcome measure The stratification of NSAID prescribing volume among the CKD population in terms of gender, age, NSAID type, dosage and prescriber type. Results The prescribing of NSAIDs in CKD patients varied between 26 and 40 % over the 5 year study period. No association between gender and CKD patients who received NSAIDs versus those who did not was found, with p > 0.05 and Cramer’s V < 0.1 for each year of the study. The association between age groups and CKD patients who received NSAIDs versus those who did not was statistically significant, but practically weak (p < 0.05; Cramer’s V ≥ 0.1). Most NSAID prescriptions (52–63 %) were for patients aged 35–64 years. Diclofenac (34.25 %) was the single most frequently prescribed NSAID, but the COX-2-inhibitors (celecoxib, meloxicam and etoricoxib) were the preferred NSAID class to be prescribed. The majority (61.6 %) of the NSAIDs were prescribed by general medical practitioners in dosages meeting and even exceeding the recommended daily dosage of patients with normal kidney function. Conclusions Even though NSAIDs are regarded as nephrotoxic drugs, they are still being prescribed to at-risk CKD patients, in particular, the elderly.
KeywordsChronic kidney disease Non-steroidal anti-inflammatory drugs NSAIDs Private health sector South Africa
Thanks should be given to Ms Anne-Marie Bekker, as she contributed with administrative support regarding the database. We also acknowledge the North-West University (Potchefstroom Campus) and the National Research Foundation (NRF) for their financial support.
Conflicts of interest
We declare that we have no financial or personal relationship(s) which may have inappropriately influenced us in writing this paper.
- 3.Solomon DH, Furst DE, Romain PL. NSAIDs: Mechanism of action. 2015. http://www.uptodate.com/contents/nsaids-mechanism-of-action. Accessed 27 Jun 2014.
- 7.McMillan JI. Chronic kidney disease. 2013. http://www.merckmanuals.com/professional/genitourinary-disorders/chronic-kidney-disease/chronic-kidney-disease. Accessed 8 Aug 2015.
- 8.Santoro D, Satta E, Messina S, Costantino G, Savica V, Bellinghieri G. Pain in end-stage renal disease: a frequent and neglected clinical problem. Clin Rheumatol. 2012;78(1):S2–11.Google Scholar
- 11.Parmar MS, Parmar KS. Management of acute and post-operative pain in chronic kidney disease. 2013. http://www.readcube.com/articles/10.12688%2Ff1000research.2-28.v3. Accessed 29 Jun 2015.
- 14.Loh AHL, Cohen AH. Drug-induced kidney disease–pathology and current concepts. Ann Acad Med. 2009;38:240–50.Google Scholar
- 15.Council for Medical Schemes, South Africa. Medical Schemes beneficiaries. 2015. http://indicators.hst.org.za/healthstats/159/data. Accessed 8 Aug 2015.
- 16.WHO (World Health Organization). International Statistical Classification of Diseases and Related Health Problems 10th Revision. http://apps.who.int/classifications/icd10/browse/2015/en#/VI. Accessed 8 Aug 2015.
- 17.MediKredit. National Pharmaceutical Product Index (NAPPI) Product Suite. 2014. https://www.medikredit.co.za/index.php?option=com_content&view=article&id=21&Itemid=31. Accessed 6 May 2014.
- 18.World Health Organization (WHO). Introduction to drug utilization research. 2003. http://www.who.int/medicines/areas/quality_safety/safety_efficacy/Drug%20utilization%20research.pdf. Accessed 26 May 2014.
- 19.Snyman, J.R., ed. 2015. Monthly Index of Medicine Specialities, 55th ed. Johannesburg: MPASA.Google Scholar
- 20.Rossiter D, editor. South African Medicine Formulary. 11th ed. Cape Town: Health and Medical; 2014.Google Scholar
- 24.Trifiró G, Sultana J, Giorgianni F, et al. Chronic kidney disease requiring healthcare services: a new approach to evaluate epidemiology of renal disease. 2014. http://www.hindawi.com/journals/bmri/2014/268362/. Access 6 Jun 2015.
- 28.Chou R, Helfand M, Peterson K, Dana T, Roberts C. Comparative effectiveness and safety of analgesics for osteoarthritis. 2006. http://www.effectivehealthcare.ahrq.gov/repFiles/AnalgesicsFinal.pdf. Accessed 17 Aug 2015.